08.07.26 -- Analytical Strategies For High-Volume GLP-1 Manufacturing

Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve purity.

Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.

Air and gas filtration are essential for sterile pharma systems. Tank vent and process gas filters help prevent contamination, protect quality, and ensure reliable, efficient operations.

Traditional quality reviews often fall short in today’s data-heavy environment. A real-time, digital-first approach enables faster insights, stronger compliance, and more proactive quality management.

Gain insight into how Agentic AI sharpens batch release workflows by surfacing faster insights, reducing manual effort, and giving teams clearer oversight. It offers a more organized route.

With a growing interest in developing new and improved bioconjugate drugs, discover an “innovation through collaboration” approach that can facilitate access to next-generation conjugation technologies.

High-mix, low-volume manufacturing demands agile visual inspection. Examine strategies to minimize changeover downtime, maintain strict compliance, and optimize operational efficiency.

Operational excellence in drug manufacturing relies on a unified culture of integrity and proactive problem-solving. Aligned global teams strengthen the supply chain for reliable patient treatments.

Outlined here are the inherent benefits of PFS and how they relate to the delivery of drugs, how SARS-CoV-2 could be fueling an explosive increase in PFS demand, and how a partnership is key to success.

Antibody-drug conjugates (ADCs) combine antibody targeting with potent cytotoxic payloads to treat resistant cancers, but their complexity requires phase-appropriate analytical strategies.

Mechanical engineering for drug-delivery devices demands more than good design — it requires data-driven risk management. Learn how a structured approach ensures global manufacturing readiness.

Uncover how biofluorescent technology with particle concentration capability consolidates viable monitoring, total particle counting, and sample collection into a single Annex 1-compliant platform.